These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice. Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141 [TBL] [Abstract][Full Text] [Related]
43. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295 [TBL] [Abstract][Full Text] [Related]
44. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy. Gordon BS; Lowe DA; Kostek MC Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286 [TBL] [Abstract][Full Text] [Related]
45. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Banks GB; Chamberlain JS Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250 [TBL] [Abstract][Full Text] [Related]
46. Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Van Ry PM; Wuebbles RD; Key M; Burkin DJ Mol Ther; 2015 Aug; 23(8):1285-1297. PubMed ID: 26050991 [TBL] [Abstract][Full Text] [Related]
47. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine. Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725 [TBL] [Abstract][Full Text] [Related]
48. Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis. Chen HC; Chin YF; Lundy DJ; Liang CT; Chi YH; Kuo P; Hsieh PCH Sci Rep; 2017 Aug; 7(1):7372. PubMed ID: 28785010 [TBL] [Abstract][Full Text] [Related]
49. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Fisher R; Tinsley JM; Phelps SR; Squire SE; Townsend ER; Martin JE; Davies KE Neuromuscul Disord; 2001 Nov; 11(8):713-21. PubMed ID: 11595513 [TBL] [Abstract][Full Text] [Related]
50. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. Tinsley JM; Fairclough RJ; Storer R; Wilkes FJ; Potter AC; Squire SE; Powell DS; Cozzoli A; Capogrosso RF; Lambert A; Wilson FX; Wren SP; De Luca A; Davies KE PLoS One; 2011 May; 6(5):e19189. PubMed ID: 21573153 [TBL] [Abstract][Full Text] [Related]
51. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice. Wang B; Li J; Fu FH; Xiao X J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234 [TBL] [Abstract][Full Text] [Related]
52. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy. Gutpell KM; Hrinivich WT; Hoffman LM PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927 [TBL] [Abstract][Full Text] [Related]
53. Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening. Moorwood C; Khurana TS Expert Opin Drug Discov; 2013 May; 8(5):569-81. PubMed ID: 23473647 [TBL] [Abstract][Full Text] [Related]
54. Muscular nitric oxide synthase (muNOS) and utrophin. Chaubourt E; Voisin V; Fossier P; Baux G; Israël M; De La Porte S J Physiol Paris; 2002; 96(1-2):43-52. PubMed ID: 11755782 [TBL] [Abstract][Full Text] [Related]
55. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. Moghadaszadeh B; Albrechtsen R; Guo LT; Zaik M; Kawaguchi N; Borup RH; Kronqvist P; Schroder HD; Davies KE; Voit T; Nielsen FC; Engvall E; Wewer UM Hum Mol Genet; 2003 Oct; 12(19):2467-79. PubMed ID: 12915458 [TBL] [Abstract][Full Text] [Related]
56. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518 [TBL] [Abstract][Full Text] [Related]
57. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657 [TBL] [Abstract][Full Text] [Related]
58. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD? Wells DJ; Wells KE Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790 [TBL] [Abstract][Full Text] [Related]
59. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658 [TBL] [Abstract][Full Text] [Related]